The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis
Open accessAbstract
. WNT/β-catenin signaling is upregulated in inflammatory processes and oxidative stress and in many cancers, although there are some exceptions for cancers. The opposite is observed with PPARγ, which is generally downregulated during inflammation and oxidative stress and in many cancers. This helps to explain in part the opposite and unidirectional profile of the canonical WNT/β-catenin signaling and PPARγ in these three frequent and morbid processes that potentiate each other and create a vicious circle. Many intracellular pathways commonly involved downstream will help maintain and amplify inflammation, oxidative stress, and cancer. Thus, many WNT/β-catenin target genes such as c-Myc, cyclin D1, and HIF-1α are involved in the development of cancers. Nuclear factor-kappaB (NFκB) can activate many inflammatory factors such as TNF-α, TGF-β, interleukin-6 (IL-6), IL-8, MMP, vascular endothelial growth factor, COX2, Bcl2, and inducible nitric oxide synthase. These factors are often associated with cancerous processes and may even promote them. Reactive oxygen species (ROS), generated by cellular alterations, stimulate the production of inflammatory factors such as NFκB, signal transducer and activator transcription, activator protein-1, and HIF-α. NFκB inhibits glycogen synthase kinase-3β (GSK-3β) and therefore activates the canonical WNT pathway. ROS activates the phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) signaling in many cancers. PI3K/Akt also inhibits GSK-3β. Many gene mutations of the canonical WNT/β-catenin pathway giving rise to cancers have been reported (CTNNB1, AXIN, APC). Conversely, a significant reduction in the expression of PPARγ has been observed in many cancers. Moreover, PPARγ agonists promote cell cycle arrest, cell differentiation, and apoptosis and reduce inflammation, angiogenesis, oxidative stress, cell proliferation, invasion, and cell migration. All these complex and opposing interactions between the canonical WNT/β-catenin pathway and PPARγ appear to be fairly common in inflammation, oxidative stress, and cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gregorio, J. D., Sferra, R., Speca, S., Vetuschi, A., Dubuquoy, C., Desreumaux, P., Pompili, S., Cristiano, L., Gaudio, E., Flati, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171093 · Cited by 56
RetractedGlobal Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · cited 1×
“org April 2018 | Volume 9 | Article 745 processes, the regulator genes of CTNNB1, AXIN, and APC have been observed to be mutated (179).”
BackgroundMacrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · cited 1×
“Tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), and tumor growth factor-β (TGF-β) are inflammatory factors involved in the regulation of the immune system (123).”
BackgroundWNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Inhibition of Adipogenesis by Wnt Signaling
Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., & MacDougald, O. A. (2000) · Science · doi:10.1126/science.289.5481.950 · Cited by 1,874
Medzhitov, R., & Janeway, C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430506 · Cited by 1,825
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · cited 2×
“Indeed, several oncogenes enhance ROS production, such as Akt (16) and c-Myc (178).”
BackgroundHussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 1×
“Leukocytes during inflammation are recruited from the damage sites and this leads to an increased uptake of oxygen, which induces the release of ROS and subsequently its accumulation (6, 149).”
BackgroundSelective Blockade of MicroRNA Processing by Lin28
Viswanathan, S. R., Daley, G. Q., & Gregory, R. I. (2008) · Science · doi:10.1126/science.1154040 · Cited by 1,437
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Forming functional fat: a growing understanding of adipocyte differentiation
Cristancho, A. G., & Lazar, M. A. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3198 · Cited by 1,382
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
Herrero, R. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg107 · Cited by 1,228
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
Proximal events in Wnt signal transduction
Angers, S., & Moon, R. T. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2717 · Cited by 1,112
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
Schwitalla, S., Fingerle, A. A., Cammareri, P., Nebelsiek, T., Göktuna, S. I., Ziegler, P. K., Canli, O., Heijmans, J., Huels, D. J., Moreaux, G., et al. (2013) · Cell · doi:10.1016/j.cell.2012.12.012 · Cited by 1,068
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Canonical Wnt signals are essential for homeostasis of the intestinal epithelium
Pinto, D., Gregorieff, A., Begthel, H., & Clevers, H. (2003) · Genes & Development · doi:10.1101/gad.267103 · Cited by 1,026
Gene Regulatory Networks in the Evolution and Development of the Heart
Olson, E. N. (2006) · Science · doi:10.1126/science.1132292 · Cited by 1,015
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Chronic inflammation and oxidative stress in human carcinogenesis
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., & Loguercio, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23192 · Cited by 1,001
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Reactive oxygen species in tumor progression
Storz, P. (2005) · Frontiers in Bioscience · doi:10.2741/1667 · Cited by 957
Unravelling cancer stem cell potential
Beck, B., & Blanpain, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3597 · Cited by 905
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778
Some Current Insights into Oxidative Stress
Ďuračková, Z. (2010) · Physiological Research · doi:10.33549/physiolres.931844 · Cited by 716
Interfaces Between the Detection, Signaling, and Repair of DNA Damage
Rouse, J., & Jackson, S. P. (2002) · Science · doi:10.1126/science.1074740 · Cited by 694
Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways
Miller, J. R., Hocking, A. M., Brown, J. D., & Moon, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1203245 · Cited by 691
Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.237 · Cited by 653
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
An Updated Overview on Wnt Signaling Pathways: A Prelude for More
Rao, T. P., & Kühl, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.219840 · Cited by 638
The contribution of endogenous sources of DNA damage to the multiple mutations in cancer
Jackson, A. L., & Loeb, L. A. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00091-4 · Cited by 630
Garcia-Gras, E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27751 · Cited by 623
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
Activation of the JAK-STAT pathway by reactive oxygen species
Simon, A. R., Rai, U., Fanburg, B. L., & Cochran, B. H. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.6.c1640 · Cited by 598
Reactive oxygen intermediates as mediators of programmed cell death in plants and animals
Jabs, T. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00227-5 · Cited by 596
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
Ma, B., & Hottiger, M. O. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00378 · Cited by 563
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms
Straus, D. S., & Glass, C. K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.003 · Cited by 554
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548
Huelsken, J., & Behrens, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00089 · Cited by 540
Oxidative stress in prostate cancer
Khandrika, L., Kumar, B., Koul, S., Maroni, P., & Koul, H. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.011 · Cited by 527
Mitochondrial generation of free radicals and hypoxic signaling
Poyton, R. O., Ball, K. A., & Castello, P. R. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.04.001 · Cited by 521
Bartsch, H., & Nair, J. (2006) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-006-0073-1 · Cited by 516
Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation
Lin, G. L., & Hankenson, K. D. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23287 · Cited by 510
Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., & Eng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80012-5 · Cited by 506
Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis
Takada, I., Kouzmenko, A. P., & Kato, S. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.137 · Cited by 504
Demetri, G. D., Fletcher, C. D. M., Mueller, E., Sarraf, P., Naujoks, R., Campbell, N., Spiegelman, B. M., & Singer, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3951 · Cited by 495
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., Doble, B., Woodgett, J., et al. (2008) · Development · doi:10.1242/dev.013540 · Cited by 492
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Peters, J. M., Shah, Y. M., & Gonzalez, F. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3214 · Cited by 492
Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene
Aoki, K., & Taketo, M. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03485 · Cited by 492
Sharma, A. M., & Staels, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1268 · Cited by 479
Rakoff-Nahoum, S. (2006) · PubMed Central · Cited by 472
Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
ten Berge, D., Kurek, D., Blauwkamp, T., Koole, W., Maas, A., Eroglu, E., Siu, R. K., & Nusse, R. (2011) · Nature Cell Biology · doi:10.1038/ncb2314 · Cited by 468
Brown, N. S., & Bicknell, R. (2001) · Breast Cancer Research · doi:10.1186/bcr315 · Cited by 462
Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31561 · Cited by 459
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
Grommes, C., Landreth, G. E., & Heneka, M. T. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01509-8 · Cited by 440
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 429
Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X.-P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180329197 · Cited by 426
Regulation of PPARγ activity during adipogenesis
Farmer, S. R. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802907 · Cited by 416
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 412
Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species
Azad, N., Rojanasakul, Y., & Vallyathan, V. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701436460 · Cited by 409
Peroxisome proliferator-activated receptor gamma and cancers.
Koeffler, H. P. (2003) · PubMed · Cited by 396
Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M. D., Moller, D. E., & Berger, J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1044 · Cited by 384
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Choi, Y. J., Lin, C.-P., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 382
Carcinogen-mediated oxidant formation and oxidative DNA damage
Frenkel, K. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90047-4 · Cited by 379
Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development
Nateri, A. S., Spencer-Dene, B., & Behrens, A. (2005) · Nature · doi:10.1038/nature03914 · Cited by 375
Tumour necrosis factor-α as a tumour promoter
Szlosarek, P., Charles, K. A., & Balkwill, F. R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.012 · Cited by 366
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
Sobolewski, C., Cerella, C., Dicato, M., Ghibelli, L., & Diederich, M. (2010) · International Journal of Cell Biology · doi:10.1155/2010/215158 · Cited by 354
Ajuwon, K. M., & Spurlock, M. E. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00397.2004 · Cited by 348
Novellasdemunt, L., Antas, P., & Li, V. S. W. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00117.2015 · Cited by 339
Williams, Z., Ben-Dov, I. Z., Elias, R., Mihailovic, A., Brown, M., Rosenwaks, Z., & Tuschl, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214046110 · Cited by 339
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
Charles, K. A., Kulbe, H., Soper, R., Escorcio-Correia, M., Lawrence, T., Schultheis, A., Chakravarty, P., Thompson, R. G., Kollias, G., Smyth, J. F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39065 · Cited by 338
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01273-3 · Cited by 336
Wnt/β-catenin signalling: from plasma membrane to nucleus
Kim, W., Kim, M., & Jho, E.-H. (2013) · Biochemical Journal · doi:10.1042/bj20121284 · Cited by 313
Inflammation by remote control
Mantovani, A. (2005) · Nature · doi:10.1038/435752a · Cited by 313
Kim, Y., Suh, N., Sporn, M., & Reed, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202458200 · Cited by 309
Molecular mechanisms underlying chronic inflammation-associated cancers
Wu, Y., Antony, S., Meitzler, J. L., & Doroshow, J. H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.08.014 · Cited by 308
p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308
Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis
MOLDES, M., ZUO, Y., MORRISON, R. F., SILVA, D., PARK, B.-H., LIU, J., & FARMER, S. R. (2003) · Biochemical Journal · doi:10.1042/bj20030426 · Cited by 307
Palakurthi, S. S., Aktaş, H., Grubissich, L., Mortensen, R. M., & Halperin, J. A. (2001) · PubMed · Cited by 302
Weyemi, U., Lagente-Chevallier, O., Boufraqech, M., Prenois, F., Courtin, F., Caillou, B., Talbot, M., Dardalhon, M., Al Ghuzlan, A., Bidart, J.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.327 · Cited by 285
Inoue, I., Goto, S.-I., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., Komoda, T., & Katayama, S. (2001) · Metabolism · doi:10.1053/meta.2001.19415 · Cited by 283
Bitarte, N., Bandres, E., Boni, V., Zarate, R., Rodriguez, J., Gonzalez-Huarriz, M., Lopez, I., Javier Sola, J., Alonso, M. M., Fortes, P., et al. (2011) · Stem Cells · doi:10.1002/stem.741 · Cited by 272
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Prost, S., Relouzat, F., Spentchian, M., Ouzegdouh, Y., Saliba, J., Massonnet, G., Beressi, J.-P., Verhoeyen, E., Raggueneau, V., Maneglier, B., et al. (2015) · Nature · doi:10.1038/nature15248 · Cited by 272
New insights on oxidative stress in cancer.
Visconti, R., & Grieco, D. (2009) · PubMed · Cited by 271
Oxidative stress in ulcerative colitis-associated carcinogenesis
Roessner, A., Kuester, D., Malfertheiner, P., & Schneider-Stock, R. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.04.011 · Cited by 271
Chronic inflammation, the tumor microenvironment and carcinogenesis
Gonda, T. A., Tu, S., & Wang, T. C. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8985 · Cited by 265
Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ
Wang, F., Mullican, S. E., DiSpirito, J. R., Peed, L. C., & Lazar, M. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314863110 · Cited by 255
Saydam, O., Shen, Y., Würdinger, T., Senol, O., Boke, E., James, M. F., Tannous, B. A., Stemmer-Rachamimov, A. O., Yi, M., Stephens, R. M., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00332-09 · Cited by 255
Phosphorylation of Serine 468 by GSK-3β Negatively Regulates Basal p65 NF-κB Activity
Buss, H., Dörrie, A., Schmitz, M. L., Frank, R., Livingstone, M., Resch, K., & Kracht, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400442200 · Cited by 252
Ghahhari, N. M., & Babashah, S. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.04.021 · Cited by 244
CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling
Noubissi, F. K., Elcheva, I., Bhatia, N., Shakoori, A., Ougolkov, A., Liu, J., Minamoto, T., Ross, J., Fuchs, S. Y., & Spiegelman, V. S. (2006) · Nature · doi:10.1038/nature04839 · Cited by 243
Functional Interaction between Peroxisome Proliferator-Activated Receptor γ and β-Catenin
Liu, J., Wang, H., Zuo, Y., & Farmer, S. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00441-06 · Cited by 241
Yang, K., Wang, X., Zhang, H., Wang, Z., Nan, G., Li, Y., Zhang, F., Mohammed, M. K., Haydon, R. C., Luu, H. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.144 · Cited by 241
Activated neutrophils induce prolonged DNA damage in neighboring cells
Shacter, E., Beecham, E. J., Covey, J. M., Kohn, K. W., & Potter, M. (1988) · Carcinogenesis · doi:10.1093/carcin/9.12.2297 · Cited by 235
How Tumors Make Bad Blood Vessels and Stroma
Dvorak, H. F. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64309-x · Cited by 230
Burstein, H. J., Demetri, G. D., Mueller, E., Sarraf, P., Spiegelman, B. M., & Winer, E. P. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024038127156 · Cited by 228
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx073 · Cited by 226 · cited 1×
“In several diseases, the WNT/β-catenin pathway and PPARγ act in an opposite manner as in cancers, such as gliomas (15, 50), neurodegenerative diseases, such as Alzheimer’s disease (51, 52), amyotrophic lateral sclerosis (53, 54), multiple sclerosis (55), age-related macular degeneration (56, 57), and fibrosis processe…”
BackgroundSelf-citationShiau, C.-W., Yang, C.-C., Kulp, S. K., Chen, K.-F., Chen, C.-S., Huang, J.-W., & Chen, C.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1677 · Cited by 222
Mechanisms of ROS modulated cell survival during carcinogenesis
Clerkin, J. S., Naughton, R., Quiney, C., & Cotter, T. G. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.029 · Cited by 219
Inflammation amplifier, a new paradigm in cancer biology
Atsumi, T., Singh, R., Sabharwal, L., Bando, H., Meng, J., Arima, Y., Yamada, M., Harada, M., Jiang, J.-J., Kamimura, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2322 · Cited by 217
Target Genes of Peroxisome Proliferator-activated Receptor γ in Colorectal Cancer Cells
Gupta, R. A., Brockman, J. A., Sarraf, P., Willson, T. M., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103779200 · Cited by 215
Motomura, W., Okumura, T., Takahashi, N., OBARA, T., & Kohgo, Y. (2000) · PubMed · doi:10.11501/3186319 · Cited by 209
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Oncotarget · doi:10.18632/oncotarget.21234 · Cited by 204
Self-citationTargeting Wnt Signaling in Colon Cancer Stem Cells
de Sousa, E. M. F., Vermeulen, L., Richel, D., & Medema, J. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1204 · Cited by 203
Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase
Ross, S. E., Erickson, R. L., Hemati, N., & MacDougald, O. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8433 · Cited by 197
Nusse, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011163 · Cited by 196
Liu, J., & Farmer, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407050200 · Cited by 187
Wnt/β-Catenin Signaling Induces the Expression and Activity of βTrCP Ubiquitin Ligase Receptor
Spiegelman, V. S., Slaga, T. J., Pagano, M., Minamoto, T., Ronai, Z., & Fuchs, S. Y. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80327-5 · Cited by 187
Endogenous Ligands for Nuclear Receptors: Digging Deeper
Schupp, M., & Lazar, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.182451 · Cited by 182
The Wnt/β-catenin signaling pathway targets PPARγ activity in colon cancer cells
Jansson, E. Å., Are, A., Greicius, G., Kuo, I.-C., Kelly, D., Arulampalam, V., & Pettersson, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405928102 · Cited by 178
Okamura, M., Kudo, H., Wakabayashi, K.-I., Tanaka, T., Nonaka, A., Uchida, A., Tsutsumi, S., Sakakibara, I., Naito, M., Osborne, T. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901676106 · Cited by 178
Koga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24024 · Cited by 175
The NF-kappaB-mediated control of ROS and JNK signaling.
Bubici, C., Papa, S., Pham, C. G., Zazzeroni, F., & Franzoso, G. (2006) · PubMed · doi:10.14670/hh-21.69 · Cited by 172
Bagi, Z., Koller, A., & Kaley, G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00718.2003 · Cited by 172
Ogino, S., Shima, K., Baba, Y., Nosho, K., Irahara, N., Kure, S., Chen, L., Toyoda, S., Kirkner, G. J., Wang, Y. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.048 · Cited by 171
Insulin resistance and cancer: Epidemiological evidence
Tsugane, S., & Inoue, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01521.x · Cited by 169
Qin, C., Burghardt, R. C., Smith, R., Wormke, M., Stewart, J., & Safe, S. H. (2003) · PubMed · Cited by 167
Regulation of β-Catenin Function by the IκB Kinases
Lamberti, C., Lin, K., Yamamoto, Y., Verma, U. N., Verma, I. M., Byers, S., & Gaynor, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104227200 · Cited by 165
IKKα Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf
Albanese, C., Wu, K., D’Amico, M., Jarrett, C. R., Joyce, D. A., Hughes, J. R., Hulit, J., Sakamaki, T., Fu, M., Ben‐Ze'ev, A., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-06-0101 · Cited by 165
The Fire Within: Microbes Inflame Tumors
Gagliani, N., Hu, B., Huber, S., Elinav, E., & Flavell, R. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.006 · Cited by 165
Wang, C., Fu, M., D'Amico, M., Albanese, C., Zhou, J.-N., Brownlee, M., Lisanti, M. P., Chatterjee, V. K. K., Lazar, M. A., & Pestell, R. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3057-3070.2001 · Cited by 165
Edderkaoui, M., Hong, P., Vaquero, E. C., Lee, J. K., Fischer, L., Friess, H., Büchler, M. W., Lerch, M. M., Pandol, S. J., & Gukovskaya, A. S. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00197.2005 · Cited by 164
Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer
Ougolkov, A., Zhang, B., Yamashita, K., Bilim, V., Mai, M., Fuchs, S. Y., & Minamoto, T. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh219 · Cited by 164
The Anti-Oxidant and Antitumor Properties of Plant Polysaccharides
Jiao, R., Liu, Y., Gao, H., Xiao, J., & So, K. F. (2016) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x16500269 · Cited by 161
A phase II trial with rosiglitazone in liposarcoma patients
Debrock, G., Vanhentenrijk, V, Sciot, R., Debiec-Rychter, M., Oyen, R., & Van Oosterom, A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601306 · Cited by 160
Simon, M., Daviaud, D., Pradère, J., Grès, S., Guigné, C., Wabitsch, M., Chun, J. J. M., Valet, P., & Saulnier‐Blache, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412585200 · Cited by 154
Kulke, M. H., Demetri, G. D., Sharpless, N. E., Ryan, D. P., Shivdasani, R. A., Clark, J. S., Spiegelman, B. M., Kim, H. T., Mayer, R. J., & Fuchs, C. S. (2002) · The Cancer Journal · doi:10.1097/00130404-200209000-00010 · Cited by 154
PPAR activators inhibit endothelial cell migration by targeting Akt
Goetze, S., Eilers, F., Bungenstock, A., Kintscher, U., Stawowy, P., Blaschke, F., Graf, K., Law, R. E., Fleck, E., & Gräfe, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00385-6 · Cited by 154
Vallée, A., & Lecarpentier, Y. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00459 · Cited by 153
Self-citationVallée, A., Guillevin, R., & Vallée, J.-N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0032 · Cited by 149
Self-citationDu, W. W., Fang, L., Li, M., Yang, X., Liang, Y.-Y., Peng, C., Wei, Q., O’Malley, Y., Askeland, R. W., Sugg, S. L., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.118299 · Cited by 147
Zhang, D., Pan, Y., Zhang, C., Yan, B., Yu, S., Wu, D., Shi, M., Shi, K., Cai, X.-X., Zhou, S., et al. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1498-1 · Cited by 147
microRNA regulation of Wnt signaling pathways in development and disease
Song, J. L., Nigam, P., Tektas, S. S., & Selva, E. M. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.03.018 · Cited by 145
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 144
Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle Regulators
Yin, F., Wakino, S., Liu, Z., Kim, S., Hsueh, W. A., Collins, A. R., Herle, A. J. V., & Law, R. E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5491 · Cited by 143
Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanoma
Kuphal, S., Poser, I., Jobin, C., Hellerbrand, C., & Bosserhoff, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207831 · Cited by 142
Sharma, C., Pradeep, A., Wong, L., Rana, A., & Rana, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403143200 · Cited by 141
Huang, J., Shiau, C., Yang, Y.-T. C., Kulp, S. K., Chen, K., Brueggemeier, R. W., Shapiro, C. L., & Chen, C. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007732 · Cited by 139
Ibrahim, E., Babaei‐Jadidi, R., Saadeddin, A., Spencer-Dene, B., Hossaini, S., Abuzinadah, M. F., Li, N.-N., Fadhil, W., Ilyas, M., Bonnet, D., et al. (2012) · Stem Cells · doi:10.1002/stem.1182 · Cited by 138
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ
Zander, T., Kraus, J. A., Grommes, C., Schlegel, U. S., Feinstein, D. L., Klockgether, T., Landreth, G. E., Koenigsknecht-Talboo, J., & Heneka, M. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00899.x · Cited by 136
Bae, M., & Song, B. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.401 · Cited by 133
Bilban, M., Haslinger, P., Prast, J., Klinglmueller, F., Woelfel, T., Haider, S., Sachs, A., Otterbein, L. E., Desoyé, G., Hiden, U., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0456 · Cited by 129
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver
Rogue, A., Spire, C., Brun, M., Claude, N., & Guillouzo, A. (2010) · PPAR Research · doi:10.1155/2010/325183 · Cited by 127
Smith, M. R., Manola, J. B., Kaufman, D. S., George, D. J., Oh, W. K., Mueller, E., Slovin, S. F., Spiegelman, B. M., Small, E. J., & Kantoff, P. W. (2004) · Cancer · doi:10.1002/cncr.20493 · Cited by 126
MicroRNA roles in beta-catenin pathway
Huang, K., Zhang, J., Han, L., You, Y., Jiang, T., Pu, P., & Kang, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-252 · Cited by 126
Sun, H., Berquin, I. M., Owens, R. T., O’Flaherty, J. T., & Edwards, I. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2305 · Cited by 125
Shah, Y. M., Morimura, K., & Gonzalez, F. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2006 · Cited by 121
Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone
Teresi, R. E., Shaiu, C., Chen, C., Chatterjee, K., Waite, K. A., & Eng, C. (2006) · International Journal of Cancer · doi:10.1002/ijc.21799 · Cited by 120
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
Biscetti, F., Gaetani, E., Flex, A., Aprahamian, T. R., Hopkins, T. A., Straface, G., Pecorini, G., Stigliano, E., Smith, R. C., Angelini, F., et al. (2008) · Diabetes · doi:10.2337/db07-0765 · Cited by 115
Jia, D., Yang, W., Li, L., Liu, H., Tan, Y., Ooi, S., Chi, L., Filion, L. G., Figeys, D., & Wang, L. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.145 · Cited by 113
Gebhardt, R., & Hovhannisyan, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22041 · Cited by 112
MicroRNAs: Synthesis, Gene Regulation and Osteoblast Differentiation
Vimalraj, S., & Selvamurugan, N. (2013) · Current Issues in Molecular Biology · doi:10.21775/cimb.015.007 · Cited by 111
Kim, N. H., Cha, Y. H., Kang, S. E., Lee, Y. M., Lee, I., Cha, S. Y., Ryu, J. K., Na, J. M., Park, C., Yoon, H., et al. (2013) · Cell Cycle · doi:10.4161/cc.24739 · Cited by 111
Fauconnet, S., Lascombe, I., Chabannes, É., Adessi, G., Desvergne, B., Wahli, W., & Bittard, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200172200 · Cited by 109
Lecarpentier, Y., CLAES, V. A., Vallée, A., & Hébert, J. (2017) · PPAR Research · doi:10.1155/2017/5879090 · Cited by 108
Self-citationActivation of PPARγ increases PTEN expression in pancreatic cancer cells
Farrow, B. J., & Evers, B. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02983-2 · Cited by 107
Yoshizumi, T., Ohta, T., Ninomiya, I., Terada, I., Fushida, S., Fujimura, T., Nishimura, G., Shimizu, K., Yi, S., & Miwa, K. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.3.631 · Cited by 107
Xu, C., Wang, J., Zhu, T., Shen, Y., Tang, X., Fang, L., & Xu, Y. (2016) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x10666150723145707 · Cited by 105
Piwien‐Pilipuk, G., Mater, D. V., Ross, S. E., MacDougald, O. A., & Schwartz, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010193200 · Cited by 103
β-Catenin Regulates Hepatic Mitochondrial Function and Energy Balance in Mice
Lehwald, N., Tao, G., Jang, K. Y., Papandreou, I., Liu, B., Liu, B., Pysz, M. A., Willmann, J. K., Knoefel, W. T., Denko, N. C., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.048 · Cited by 102
Lecarpentier, Y., CLAES, V. A., Duthoit, G., & Hébert, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00429 · Cited by 102
Self-citationPPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
Aljada, A., O’Connor, L., Fu, Y.-Y., & Mousa, S. A. (2008) · Angiogenesis · doi:10.1007/s10456-008-9118-0 · Cited by 100
PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression
Lee, S. Y., Hur, G. Y., Jung, K. H., Jung, H. C., Lee, S. Y., Kim, J. H., Shin, C., Shim, J. J., In, K. H., Kang, K. H., et al. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.10.010 · Cited by 98
Connective tissue growth factor inhibits adipocyte differentiation
Tan, J. T. M., McLennan, S. V., Song, W. W., Lo, L. W.-Y., Bonner, J. G., Williams, P. F., & Twigg, S. M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00333.2007 · Cited by 98
Park, J., Mangal, D., Frey, A. J., Harvey, R. G., Blair, I. A., & Penning, T. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042143 · Cited by 96
MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin
Wang, X., Ji, C., Feng, L., Lin, Y., Zhang, X., Lv, Z., & Jiang, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.039 · Cited by 95
PPAR-γ agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts
Chintalgattu, V., HARRIS, G., Akula, S. M., & Katwa, L. C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.010 · Cited by 94
Research works printed but not linked: 7
- Yamasaki, 2004, Cytokines regulate fibroblast-like synovial cell differentiation to adipocyte-like cells, Rheumatology (Oxford), 43, 448, 10.1093/rheumatology/keh092 · doi:10.1093/rheumatology/keh092
- He, 2007, Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases, Chin Med J (Engl), 120, 1498, 10.1097/00029330-200709010-00007 · doi:10.1097/00029330-200709010-00007
- Aldred, 2003, Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas, Oncogene, 22, 3412, 10.1038/sj.onc.1206400 · doi:10.1038/sj.onc.1206400
- Terashita, 2002, Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer, Jpn J Clin Oncol, 32, 238, 10.1093/jjco/hyf056 · doi:10.1093/jjco/hyf056
- Bambury, 2013, Specific PPAR gamma agonists may have different effects on cancer incidence, Annu Oncol Off, 24, 854, 10.1093/annonc/mdt003 · doi:10.1093/annonc/mdt003
- Liu, 2013, Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro, Tumour Biol, 34, 2409, 10.1007/s13277-013-0791-2 · doi:10.1007/s13277-013-0791-2
- Kim, 2006, Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells, Biochem Pharmacol, 72, 530, 10.1016/j.bcp.2006.05.009 · doi:10.1016/j.bcp.2006.05.009
Cited by
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Wang, Y., Nakajima, T., Gonzalez, F. J., & Tanaka, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062061 · Cited by 540
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
WNT/β-catenin signaling in the development of liver cancers
He, S., & Tang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110851 · Cited by 351
Li, Z., Zhu, S., Liu, Q., Wei, J., Jin, Y., Wang, X., & Zhang, L. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115025 · Cited by 301
Red Beetroot and Betalains as Cancer Chemopreventative Agents
Lechner, J. F., & Stoner, G. D. (2019) · Molecules · doi:10.3390/molecules24081602 · Cited by 122
Metadata
- Authors
- Vallée, A., & Lecarpentier, Y.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-13
- Volume
- 9
- Pages
- 745-745
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2797499614
- Cited by
- 374
- References
- 284
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.